+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06099119

Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy with Standard Care for Patients with Unresectable Pancreatic Cancer

Led by Hospital Clinico Universitario de Santiago · Updated on 2026-09-21

100

Participants Needed

4

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with unresectable pancreatic cancer that is locally advanced or metastatic, focusing on those who have significant weight loss and a tumor located in the head of the pancreas with a dilated main pancreatic duct. The study evaluates the addition of Pancreatic Exocrine Replacement Therapy PERT alongside the best standard of care, including cancer treatments, diabetes management, acid suppressants, and nutritional support. This is an open-label, randomized, controlled Phase 4 trial lasting up to six months. Participants are randomly assigned to one of two groups. The experimental group receives the best standard of care plus PERT, consisting of Creon 35,000 Ph.U capsules taken three times with main meals and twice with snacks daily for six months. The control group receives the best standard of care alone for the first three months, followed by the addition of PERT at the same dose during an open-label phase for the final three months. All participants take a proton pump inhibitor twice daily while on PERT. During the study, participants are monitored for changes in body weight from the start to six months to evaluate the therapys impact. Researchers also assess adherence to treatments and manage any associated therapies. The trial includes regular visits and evaluations to track progress, safety, and response to the treatment over the six-month period.

CONDITIONS

Brief Title

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

Research Team

J

J. Enrique Dominguez-Munoz, PhD, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here